Home Cart Sign in  
Chemical Structure| 2210228-45-6 Chemical Structure| 2210228-45-6

Structure of SU0268
CAS No.: 2210228-45-6

Chemical Structure| 2210228-45-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SU0268 is a potent and selective OGG1 inhibitor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SU0268

CAS No. :2210228-45-6
Formula : C26H25N3O4S
M.W : 475.56
SMILES Code : O=C(C1=CC(C2=CC=C(S(=O)(NC3=CC4=C(C=C3)CCCN4C(C5CC5)=O)=O)C=C2)=CC=C1)N
MDL No. :MFCD34474075
InChI Key :XGGNCZLDTJOSFV-UHFFFAOYSA-N
Pubchem ID :154934526

Safety of SU0268

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of SU0268

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse alveolar macrophages (MH-S cells) 2 µM 0, 4, 8, 12 hours To evaluate the inhibitory effect of SU0268 on OGG1 activity and its modulation of inflammatory responses. Results showed that SU0268 significantly inhibited OGG1 activity and reduced the expression of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β. J Immunol. 2020 Oct 15;205(8):2231-2242
U2OS cells 10 µM 1 hour To evaluate the effect of SU0268 on U2OS cells, results showed that SU0268 significantly increased the accumulation of fluorescent dyes in cells. Front Cell Dev Biol. 2023 Feb 3;11:1124960
HeLa cells 100 µM, 10 µM, 1 µM, 100 nM, and 10 nM 24 hours To test the cytotoxicity of SU0268, results showed no significant toxicity at 10 μM J Am Chem Soc. 2018 Feb 14;140(6):2105-2114
HEK293T cells 100 µM, 10 µM, 1 µM, 100 nM, and 10 nM 24 hours To test the cytotoxicity of SU0268, results showed no significant toxicity at 10 μM J Am Chem Soc. 2018 Feb 14;140(6):2105-2114
A549 lung adenocarcinoma cells 0.1 µM, 0.5 µM, 1 µM, 2.5 µM, 5 µM, 7.5 µM, 10 µM 24 or 48 hours Evaluate the effect of SU0268 in shMTH1-transduced cells vs. control shGFP-transduced cells. Found that shMTH1 cells exhibited increasing relative viability compared to shGFP at higher SU0268 concentrations. Redox Biol. 2021 Apr;40:101848
H460 lung adenocarcinoma cells 10 µM or 20 µM 48 and 72 hours Evaluate the effect of SU0268 alone or in combination with IACS-4759. Found that SU0268 treatment alone produced a small but statistically significant increase in viability. Redox Biol. 2021 Apr;40:101848
HCT116 colorectal cancer cells 10 µM or 20 µM 48 hours Evaluate the effect of SU0268 alone or in combination with IACS-4759. Found that 20 μM SU0383 treatment led to a noticeable decrease in cell viability. Redox Biol. 2021 Apr;40:101848
Primary alveolar macrophages (PAMs) 10 µM 6 hours Inhibited OGG1 activity, reduced ASFV replication and transcription levels. Virol Sin. 2023 Feb;38(1):96-107

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6N mice Pseudomonas aeruginosa (PA14) infection model Intranasal administration 10 mg/kg Single dose, lasting 12 hours To evaluate the inhibitory effect of SU0268 on inflammatory responses and its modulation of bacterial infection in vivo. Results showed that SU0268 pretreatment significantly improved survival rates, reduced bacterial burden, and alleviated lung tissue damage. J Immunol. 2020 Oct 15;205(8):2231-2242

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.10mL

0.42mL

0.21mL

10.51mL

2.10mL

1.05mL

21.03mL

4.21mL

2.10mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories